ocrelizumab - CISMeF

Preferred Label : ocrelizumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T129 - Immunologic Factor; T121 - Pharmacologic Substance;

Is substance : O;

Détails

Origin ID

M0527347;

UMLS CUI

C1882138;

Currated CISMeF NLP mapping
- Ocrelizumab [SMS substance]
- Ocrelizumab [ICD-11 Extension code]
- Ocrelizumab [NCIt concept]
- Ocrelizumab (substance) [SNOMED CT concept]
MeSH narrower concept(s)
- PR 070769 [MeSH concept]
- R 1594 [MeSH concept]
- RG-1594 [MeSH concept]
Related MeSH concept(s)
- Ocrevus [MeSH concept]
Related record
- ocrelizumab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing ocrelizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ocrelizumab [NCIt concept]
- Ocrelizumab (substance) [SNOMED CT concept]
- Product containing ocrelizumab (medicinal product) [SNOMED CT concept]
- ocrelizumab [ATC Code]
Validated automatic mappings to BTNT
- ocrelizumab [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients